This inventor holds 1 USPTO granted patent. Top assignee: University of Colorado. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Glen C Post: Innovator in Cancer Treatment
Introduction
Glen C Post is a notable inventor based in Spokane, WA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Glen C Post holds 1 patent for his invention titled "Methods of treating cancer with doxazolidine and prodrugs thereof." This invention provides therapeutically effective compounds for the prevention and treatment of cancer. It includes pharmaceutical compositions containing these compounds, as well as methods for using and administering them. Additionally, the invention encompasses methods for activating a prodrug of these therapeutically effective compounds by administering a peptide-directed targeting construct that delivers a prodrug-activating enzyme to a target activation site.
Career Highlights
Glen C Post is affiliated with the University of Colorado, where he continues to advance his research in cancer treatment. His work has the potential to significantly impact the medical field and improve patient outcomes.
Collaborations
He has collaborated with notable colleagues such as Brian T Kalet and Daniel L Rudnicki, contributing to a rich environment of innovation and research.
Conclusion
Glen C Post's work exemplifies the vital role of inventors in developing new treatments for serious health conditions. His contributions to cancer therapy highlight the importance of innovation in medicine.